Literature DB >> 2052589

Alloreactive T cells discriminate among a diverse set of endogenous peptides.

W R Heath1, K P Kane, M F Mescher, L A Sherman.   

Abstract

Previous studies have demonstrated that class I major histocompatibility complex (MHC) molecules are occupied by peptides of endogenously synthesized self proteins. Since graft rejection appears to be mediated by the normal occurrence of high frequencies of cytolytic T lymphocytes (CTLs) specific for allogeneic MHC molecules, it is important to know if such CTLs recognize specific MHC-peptide complexes (as opposed to the MHC molecule per se) and, if so, whether allorecognition is the result of the recognition of a limited spectrum of antigenic determinants or, alternatively, the recognition of a diverse array of MHC-self peptide complexes. This issue has been examined using a mutant cell line, T2Kb, that expresses class I molecules devoid of endogenously derived peptides. This cell line was not recognized by Kb-specific alloreactive CTLs. However, upon exposure to peptides derived by cyanogen bromide cleavage of cytoplasmic proteins these cells became sensitized for recognition and lysis by a majority of the CTL clones examined. Reverse-phase HPLC fractionation of the heterogeneous cell-derived peptides revealed that individual CTL clones were specific for different peptide antigen(s). Thus, the high frequency of alloreactive T cells that is responsible for graft rejection appears to represent the sum of numerous T-cell clones specific for a diverse array of endogenous peptide antigens presented in the context of allogeneic class I molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052589      PMCID: PMC51819          DOI: 10.1073/pnas.88.12.5101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition.

Authors:  W R Heath; L A Sherman
Journal:  Eur J Immunol       Date:  1991-01       Impact factor: 5.532

2.  Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.

Authors:  T N Schumacher; M T Heemels; J J Neefjes; W M Kast; C J Melief; H L Ploegh
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

3.  Presentation of viral antigen controlled by a gene in the major histocompatibility complex.

Authors:  V Cerundolo; J Alexander; K Anderson; C Lamb; P Cresswell; A McMichael; F Gotch; A Townsend
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

4.  Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?

Authors:  P Matzinger; M J Bevan
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

5.  Defective presentation of endogenous antigen by a cell line expressing class I molecules.

Authors:  N A Hosken; M J Bevan
Journal:  Science       Date:  1990-04-20       Impact factor: 47.728

6.  Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule.

Authors:  T J Elliott; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Mapping of epitopes recognized by alloreactive cytotoxic T lymphocytes using inhibition by MHC peptides.

Authors:  W R Heath; A Vitiello; L A Sherman
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

8.  Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes.

Authors:  W R Heath; M E Hurd; F R Carbone; L A Sherman
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

9.  Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC.

Authors:  J Schneck; W L Maloy; J E Coligan; D H Margulies
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

10.  Introduction of soluble protein into the class I pathway of antigen processing and presentation.

Authors:  M W Moore; F R Carbone; M J Bevan
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

View more
  31 in total

1.  Pillars article: Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992. 255: 1261-1263.

Authors:  Donald F Hunt; Robert A Henderson; Jeffrey Shabanowitz; Kazuyasu Sakaguchi; Hanspeter Michel; Noelle Sevilir; Andrea L Cox; Ettore Appella; Victor H Engelhard
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

2.  Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells.

Authors:  R A Henderson; A L Cox; K Sakaguchi; E Appella; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

Review 3.  Conformational changes in MHC class I molecules. Antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system.

Authors:  K D Smith; Z B Kurago; C T Lutz
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

4.  Allelic variations clustered in the antigen binding sites of HLA-Bw62 molecules.

Authors:  S Y Choo; L A Fan; J A Hansen
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone.

Authors:  K Udaka; T J Tsomides; P Walden; N Fukusen; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

6.  Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation.

Authors:  K D Smith; D F Epperson; C T Lutz
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

7.  A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligands.

Authors:  Christina Bade-Doeding; Holger-Andreas Elsner; Britta Eiz-Vesper; Axel Seltsam; Ute Holtkamp; Rainer Blasczyk
Journal:  Immunogenetics       Date:  2004-04-30       Impact factor: 2.846

8.  Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens.

Authors:  Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Elena Merino; José A López de Castro; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

9.  The peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains.

Authors:  J M Connolly
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

10.  Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.

Authors:  K Kurokohchi; T Akatsuka; C D Pendleton; A Takamizawa; M Nishioka; M Battegay; S M Feinstone; J A Berzofsky
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.